FDA Person
Office of the CommissionerAndrew J. Idzior
View detailed information about Andrew J. Idzior, including compliance records, violations, and related data.
Person Profile
FDA investigator, Office of the Commissioner. Took part in 21 inspections of 21 companies, 2017–2018.
Inspections (21)
See all 21 inspections in the dashboard
Documents (9)
- 483 · Caraco Pharmaceutical Laboratories, Ltd. · January 11, 2013
- 483 · Caraco Pharmaceutical Laboratories, Ltd. · May 30, 2013
- 483 · Lupin Limited · April 7, 2017
- 483 · TENTAMUS INDIA PRIVATE LIMITED · July 15, 2016
- 483 · Medline Industries, Inc · May 22, 2018
- 483 · Medline Industries, LP · May 25, 2018
- 483 · Catalent CTS, LLC · October 23, 2018
- EIR · Bell Pharmaceuticals, Inc · April 6, 2018
- 483 · Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. · May 19, 2017
Frequently inspected with (8)
Azza Talaat
2 shared
Jogy George
2 shared
Ross J. Grigsby
2 shared
Carrie A. Hughes
1 shared
Eric L. Dong
1 shared
Michele Perry-Williams
Investigator
1 shared
Wayne D. Mcgrath
1 shared
Yaodong Huang
1 shared
Related Office
Person Information
Name
Andrew J. Idzior
Title
Investigator
Role
Regulatory Personnel
ID: 5b639c02-d062-4a5a-aa4a-8362ddfba2b6
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.